Neda Hashemi, MD, is a triple board-certified medical oncologist and hematologist. Dr. Hashemi earned her medical degree from Iran University of Medical Sciences in Tehran. She went on to complete a neuro-oncology research fellowship at Cleveland Clinic, followed by internal medicine residency at the University of Texas Health Science Center in Houston, where she was honored as the Outstanding Graduating Resident of the Year. Her training continued at Indiana University, where she completed her hematology/oncology fellowship and served as chief fellow.
Prior to joining Ironwood, Dr. Hashemi was a faculty member and Associate Professor at the University of New Mexico Comprehensive Cancer Center. There, she led the Genitourinary Working Group and helped launch the center’s Prostate Cancer Theranostic Program. She also served as Medical Director of the New Mexico Cancer Research Alliance and chaired the center’s Protocol Review and Monitoring Committee. Nationally, she contributed to research as the Community Representative of the National Cancer Institute’s Prostate Cancer Task Force.
Dr. Hashemi has served as a site principal investigator on numerous clinical trials and has authored peer-reviewed publications in leading journals. She is a frequent invited speaker at regional conferences in oncology and urology.
Dr. Hashemi specializes in genitourinary and lung, head & neck cancers, including cancers of the prostate, kidney, bladder, testis, penis, lung, oral, nasal cavity, and thyroid. She brings a deep commitment to personalized, compassionate care and advanced cancer treatment to Ironwood Cancer Research Centers. Her philosophy of care centers on treating the whole person—not just the disease. She is deeply honored to walk alongside her patients through their cancer journey, offering both cutting-edge therapies and heartfelt support.
Medical Oncologist & Hematologist
Hashemi-Sadraei N, Einhorn LH, Perkins S, Spinella MJ, Fang F, Hanna NH, Nephew KP, Albany C.
Safety and tolerability of guadecitabine (SGI-110) plus cisplatin in patients with platinum-refractory germ cell tumors (GCT): Preliminary results from an open-label phase 1b study.
Presented at: American Society of Clinical Oncology (ASCO) Annual Meeting; June 1–4, 2018; Chicago, IL.
Published in: Journal of Clinical Oncology. 2018;36(suppl): abstr e16545.
Hashemi‑Sadraei N, Adra N, Kesler KA, Idrees MT, Boothman DA, Einhorn L.
Tissue analysis of NAD(P)H: quinone oxidoreductase (NQO1) and catalase expression in patients with germ cell tumors. Poster presented at the AACR Virtual Annual Meeting II, June 22–23, 2020. Published in Cancer Research 2020; 80(16 Suppl): Abstract 5169.
Gbolahan O, Outlaw DA, Hashemi-Sadraei N, Paluri RV, Williams GR.
Impact of time to treatment initiation on real-world (RW) outcomes in metastatic pancreatic cancer (mPC) in the United States.
Presented at: American Society of Clinical Oncology (ASCO) Annual Meeting Virtual; June 4–8, 2021.
Journal of Clinical Oncology. 2021;39(15_suppl):e16254.
Brown J, Kaimakliotis HZ, Kelly WK, Ammons V, Picus J, Walling R, Hashemi-Sadraei N, Fu P, Margevicius SP, Adra N, Garcia JA, McKay RR, Hoimes CJ.
HCRN GU14-188: Phase Ib/II study of neoadjuvant pembrolizumab and chemotherapy for T2-4aN0M0 urothelial cancer. Rapid Abstract Session at the American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium (GU-ASCO), San Francisco, CA, February 16–18, 2023. Journal of Clinical Oncology. 2023;41(suppl 6):abstr 448.
Shilling MW, Hashemi‑Sadraei N, Shah SK.
Geographic variations in corporate sponsorship for cancer center charity events. Poster presented at the 2024 ASCO Annual Meeting; May 30 – June 3, 2024. Published in Journal of Clinical Oncology. 2024; 42(suppl 16): e23116
Chief Resident Internal Medicine Residency (2021-2022) East Tennessee State University, Johnson City, TN
Internal Medicine Representative for the Resident Leadership Committee
East Tennessee State University, Johnson City, TN
The milestone award for systems-based practice at East Tennessee State University Student representative on curriculum development committee in my medical school.
Research Mentorship Excellence Award 2023-2024, for the support of the Hematology and Oncology ACGME fellowship for University of New Mexico, Comprehensive Cancer Center, Albuquerque, NM
2021 Ian Rabinowitz Award for Teaching Excellence 2020-, for the support of the Hematology and Oncology ACGME fellowship for University of New Mexico, Comprehensive Cancer Center, Albuquerque, NM
2018 Selected participant for AACR/ASCO Vail Methods in Clinical Cancer Research Workshop, Vail, Colorado
2017 George and Sarah Jane Fisher Young Investigator Award A $15,000 research grant awarded by Hoosier Cancer Research Network (HCRN), Indianapolis, IN
2015 Outstanding Graduating Resident of the Year, 2014-2015 (class of 36), University of Texas Health Science Center at Houston, Houston, TX
2011 Second Place Award, Associate Research Category Poster Competition, American College of Physicians (ACP) Ohio Chapter Meeting, Columbus, OH
No videos found.
695 S. Dobson Rd
Chandler, AZ 85224
Hours:
Monday- Friday
8am-5pm
3686 S. Rome St.
Gilbert, AZ 85297
Hours:
Monday- Friday
8am-5pm
